Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis

Human Molecular Genetics

Volumn 20, Issue 12, 2011, Pages 2344-2355

  Reis, Surya A ^a   Thompson, Morgan N ^a   Lee, Jong Min ^a   Fossale, Elisa ^a   Kim, Hyung Hwan ^b   Liao, James K ^b   Moskowitz, Michael A ^a   Shaw, Stanley Y ^a   Dong, Linda ^a   Haggarty, Stephen J ^a   MacDonald, Marcy E ^a   Seong, Ihn Sik ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ADENOSINE TRIPHOSPHATE; HUNTINGTIN; MUTANT PROTEIN; NERVE CELL ADHESION MOLECULE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CORPUS STRIATUM; MOUSE; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SYNAPSE VESICLE;

ADENINE; ADENOSINE TRIPHOSPHATE; ANIMALS; CADHERINS; CELL ADHESION; CELLS, CULTURED; CORPUS STRIATUM; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE KNOCK-IN TECHNIQUES; HUMANS; HUNTINGTON DISEASE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MUTATION; NERVE TISSUE PROTEINS; NEURITES; NEURONS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 79957440957     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr127     Document Type: Article

References (59)

1. Vonsattel, J.P. and DiFiglia, M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol., 57, 369-384.
2. The Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
3. Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De Mey, J., MacDonald, M.E., Lessmann, V., Humbert, S. et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell, 118, 127-138.
4. Reddy, P.H., Mao, P. and Manczak, M. (2009) Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res. Rev., 61, 33-48.
5. Truant, R., Atwal, R. and Burtnik, A. (2006) Hypothesis: huntingtin may function in membrane association and vesicular trafficking. Biochem. Cell Biol., 84, 912-917.
6. Carnevale, F.A., Macdonald, M.E., Bluebond-Langner, M. and McKeever, P. (2008) Using participant observation in pediatric health care settings: ethical challenges and solutions. J. Child Health Care, 12, 18-32.
7. Seong, I.S., Ivanova, E., Lee, J.M., Choo, Y.S., Fossale, E., Anderson, M., Gusella, J.F., Laramie, J.M., Myers, R.H., Lesort, M. et al. (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum. Mol. Genet., 14, 2871-2880.
8. Gines, S., Seong, I.S., Fossale, E., Ivanova, E., Trettel, F., Gusella, J.F., Wheeler, V.C., Persichetti, F. and MacDonald, M.E. (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum. Mol. Genet., 12, 497-508.
9. Lee, J.M., Ivanova, E.V., Seong, I.S., Cashorali, T., Kohane, I., Gusella, J.F. and MacDonald, M.E. (2007) Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism. PLoS Genet., 3., e135.
10. Mochel, F., Charles, P., Seguin, F., Barritault, J., Coussieu, C., Perin, L., Le Bouc, Y., Gervais, C., Carcelain, G., Vassault, A. et al. (2007) Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One, 2, e647.
11. Benson, D.L., Colman, D.R. and Huntley, G.W. (2001) Molecules, maps and synapse specificity. Nat. Rev. Neurosci., 2, 899-909.
12. Takeichi, M. (2007) The cadherin superfamily in neuronal connections and interactions. Nat. Rev. Neurosci., 8, 11-20.
13. Mandel, L.J., Doctor, R.B. and Bacallao, R. (1994) ATP depletion: a novel method to study junctional properties in epithelial tissues. II. Internalization of Na+,K(+)-ATPase and E-cadherin. J. Cell Sci., 107, 3315-3324.
14. Bush, K.T., Tsukamoto, T. and Nigam, S.K. (2000) Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am. J. Physiol. Renal Physiol., 278, F847-852.
15. Covington, M.D., Bayless, K.J., Burghardt, R.C., Davis, G.E. and Parrish, A.R. (2005) Ischemia-induced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases. Am. J. Physiol. Renal Physiol., 289, F280-F288.
16. Covington, M.D., Burghardt, R.C. and Parrish, A.R. (2006) Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am. J. Physiol. Renal Physiol., 290, F43-F51.
17. Hatta, K., Nose, A., Nagafuchi, A. and Takeichi, M. (1988) Cloning and expression of cDNA encoding a neural calcium-dependent cell adhesion molecule: its identity in the cadherin gene family. J. Cell Biol., 106, 873-881.
18. Takeichi, M. (1990) Cadherins: a molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem., 59, 237-252.
19. Aberle, H., Butz, S., Stappert, J., Weissig, H., Kemler, R. and Hoschuetzky, H. (1994) Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J. Cell Sci., 107, 3655-3663.
20. Knudsen, K.A., Soler, A.P., Johnson, K.R. and Wheelock, M.J. (1995) Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J. Cell Biol., 130, 67-77.
21. Baki, L., Marambaud, P., Efthimiopoulos, S., Georgakopoulos, A., Wen, P., Cui, W., Shioi, J., Koo, E., Ozawa, M., Friedrich, V.L. Jr et al. (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl Acad. Sci. USA, 98, 2381-2386.
22. Gumbiner, B.M. (2000) Regulation of cadherin adhesive activity. J. Cell Biol., 148, 399-404.
23. Namura, S., Hirt, L., Wheeler, V.C., McGinnis, K.M., Hilditch-Maguire, P., Moskowitz, M.A., MacDonald, M.E. and Persichetti, F. (2002) The HD mutation does not alter neuronal death in the striatum of Hdh(Q92) knock-in mice after mild focal ischemia. Neurobiol. Dis., 11, 147-154.
24. Kim, M., Roh, J.K., Yoon, B.W., Kang, L., Kim, Y.J., Aronin, N. and DiFiglia, M. (2003) Huntingtin is degraded to small fragments by calpain after ischemic injury. Exp. Neurol., 183, 109-115.
25. Peyrieras, N., Hyafil, F., Louvard, D., Ploegh, H.L. and Jacob, F. (1983) Uvomorulin: a nonintegral membrane protein of early mouse embryo. Proc. Natl Acad. Sci. USA, 80, 6274-6277.
26. Yoshida, C. and Takeichi, M. (1982) Teratocarcinoma cell adhesion: identification of a cell-surface protein involved in calcium-dependent cell aggregation. Cell, 28, 217-224.
27. Bixby, J.L. and Zhang, R. (1990) Purified N-cadherin is a potent substrate for the rapid induction of neurite outgrowth. J. Cell Biol., 110, 1253-1260.
28. Goodwin, M. and Yap, A.S. (2004) Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton. J. Mol. Histol., 35, 839-844.
29. Bamji, S.X. (2005) Cadherins: actin with the cytoskeleton to form synapses. Neuron, 47, 175-178.
30. Muhlrad, A., Ringel, I., Pavlov, D., Peyser, Y.M. and Reisler, E. (2006) Antagonistic effects of cofilin, beryllium fluoride complex, and phalloidin on subdomain 2 and nucleotide-binding cleft in F-actin. Biophys. J., 91, 4490-4499.
31. Regalado, M.P., Terry-Lorenzo, R.T., Waites, C.L., Garner, C.C. and Malenka, R.C. (2006) Transsynaptic signaling by postsynaptic synapse-associated protein 97. J. Neurosci., 26, 2343-2357.
32. Togashi, H., Abe, K., Mizoguchi, A., Takaoka, K., Chisaka, O. and Takeichi, M. (2002) Cadherin regulates dendritic spine morphogenesis. Neuron, 35, 77-89.
33. Bamji, S.X., Shimazu, K., Kimes, N., Huelsken, J., Birchmeier, W., Lu, B. and Reichardt, L.F. (2003) Role of beta-catenin in synaptic vesicle localization and presynaptic assembly. Neuron, 40, 719-731.
34. Bozdagi, O., Valcin, M., Poskanzer, K., Tanaka, H. and Benson, D.L. (2004) Temporally distinct demands for classic cadherins in synapse formation and maturation. Mol. Cell Neurosci., 27, 509-521.
35. Garner, C.C., Waites, C.L. and Ziv, N.E. (2006) Synapse development: still looking for the forest, still lost in the trees. Cell Tissue Res., 326, 249-262.
36. Clabough, E.B. and Zeitlin, S.O. (2006) Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro. Hum. Mol. Genet., 15, 607-623.
37. Trettel, F., Rigamonti, D., Hilditch-Maguire, P., Wheeler, V.C., Sharp, A.H., Persichetti, F., Cattaneo, E. and MacDonald, M.E. (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet., 9, 2799-2809.
38. Braga, V.M. (1999) Small GTPases and regulation of cadherin dependent cell-cell adhesion. Mol. Pathol., 52, 197-202.
39. Watanabe, T., Sato, K. and Kaibuchi, K. (2009) Cadherin-mediated intercellular adhesion and signaling cascades involving small GTPases. Cold Spring Harb. Perspect. Biol., 1, a003020.
40. Swayne, L.A., Chen, L., Hameed, S., Barr, W., Charlesworth, E., Colicos, M.A., Zamponi, G.W. and Braun, J.E. (2005) Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels. Mol. Cell Neurosci., 30, 339-351.
41. Markianos, M., Panas, M., Kalfakis, N. and Vassilopoulos, D. (2008) Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives. Mol. Genet. Metab., 93, 341-346.
42. Valenza, M., Leoni, V., Karasinska, J.M., Petricca, L., Fan, J., Carroll, J., Pouladi, M.A., Fossale, E., Nguyen, H.P., Riess, O. et al. (2010) Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes. J. Neurosci., 30, 10844-10850.
43. Pardo, R., Molina-Calavita, M., Poizat, G., Keryer, G., Humbert, S. and Saudou, F. (2010) pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking. Mol. Brain, 3, 17.
44. Pal, A., Severin, F., Lommer, B., Shevchenko, A. and Zerial, M. (2006) Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J. Cell Biol., 172, 605-618.
45. Martinez-Vicente, M., Talloczy, Z., Wong, E., Tang, G., Koga, H., Kaushik, S., de Vries, R., Arias, E., Harris, S., Sulzer, D. et al. (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci., 13, 567-576.
46. Strehlow, A.N., Li, J.Z. and Myers, R.M. (2007) Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space. Hum. Mol. Genet., 16, 391-409.
47. Bruses, J.L. (2006) N-cadherin signaling in synapse formation and neuronal physiology. Mol. Neurobiol., 33, 237-252.
48. Tan, Z.J., Peng, Y., Song, H.L., Zheng, J.J. and Yu, X. (2010) N-cadherin-dependent neuron-neuron interaction is required for the maintenance of activity-induced dendrite growth. Proc. Natl Acad. Sci. USA, 107, 9873-9878.
49. Stan, A., Pielarski, K.N., Brigadski, T., Wittenmayer, N., Fedorchenko, O., Gohla, A., Lessmann, V., Dresbach, T. and Gottmann, K. (2010) Essential cooperation of N-cadherin and neuroligin-1 in the transsynaptic control of vesicle accumulation. Proc. Natl Acad. Sci. USA, 107, 11116-11121.
50. Molero, A.E., Gokhan, S., Gonzalez, S., Feig, J.L., Alexandre, L.C. and Mehler, M.F. (2009) Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proc. Natl Acad. Sci. USA, 106, 21900-21905.
51. Nopoulos, P.C., Aylward, E.H., Ross, C.A., Mills, J.A., Langbehn, D.R., Johnson, H.J., Magnotta, V.A., Pierson, R.K., Beglinger, L.J., Nance, M.A. et al. (2011) Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain, 134, 137-142.
52. Lynch, G., Kramar, E.A., Rex, C.S., Jia, Y., Chappas, D., Gall, C.M. and Simmons, D.A. (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J. Neurosci., 27, 4424-4434.
53. Simmons, D.A., Rex, C.S., Palmer, L., Pandyarajan, V., Fedulov, V., Gall, C.M. and Lynch, G. (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc. Natl Acad. Sci. USA, 106, 4906-4911.
54. Jenkins, B.G., Rosas, H.D., Chen, Y.C., Makabe, T., Myers, R., MacDonald, M., Rosen, B.R., Beal, M.F. and Koroshetz, W.J. (1998) 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. Neurology, 50, 1357-1365.
55. Saft, C., Zange, J., Andrich, J., Muller, K., Lindenberg, K., Landwehrmeyer, B., Vorgerd, M., Kraus, P.H., Przuntek, H. and Schols, L. (2005) Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov. Disord., 20, 674-679.
56. Sturrock, A. and Leavitt, B.R. (2010) The clinical and genetic features of Huntington disease. J. Geriatr. Psychiatry Neurol., 23, 243-259.
57. Wheeler, V.C., Auerbach, W., White, J.K., Srinidhi, J., Auerbach, A., Ryan, A., Duyao, M.P., Vrbanac, V., Weaver, M., Gusella, J.F. et al. (1999) Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum. Mol. Genet., 8, 115-122.
58. Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M.A. and Liao, J.K. (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA, 95, 8880-8885.
59. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.